These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 21453273)

  • 1. Clinically relevant genetic variations in drug metabolizing enzymes.
    Pinto N; Dolan ME
    Curr Drug Metab; 2011 Jun; 12(5):487-97. PubMed ID: 21453273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic variations affect drug safety and efficacy].
    Harmsze AM; Deneer VH; Maitland-van der Zee AH; de Boer A; Klungel OH
    Ned Tijdschr Geneeskd; 2010; 154():A1503. PubMed ID: 20699026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic information in the Warning section of drug labels: A comparison between labels in the United States and those in five other countries/regions.
    Imatoh T; Sai K; Saito Y
    J Clin Pharm Ther; 2018 Aug; 43(4):493-499. PubMed ID: 29682780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity.
    Hart SN; Zhong XB
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):439-52. PubMed ID: 18433346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reaction monitoring in Jena. Relevance of polymorphic drug metabolizing enzymes for inducing adverse drug reactions.
    Hippius M; Buchardt C; Farker K; Kuhn UD; Reimann IR; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):417-21. PubMed ID: 12877354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PG-path: Modeling and personalizing pharmacogenomics-based pathways.
    Hong JY; Kim JH
    PLoS One; 2020; 15(5):e0230950. PubMed ID: 32365122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic implications of polymorphisms in cytochromes and drug transporters].
    Münster E; Ziegler S; Brunner M
    Wien Med Wochenschr; 2005 Feb; 155(3-4):54-8. PubMed ID: 15791777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From the Viewpoint of Drug Metabolism Research].
    Nakajima M
    Yakugaku Zasshi; 2017; 137(6):697-705. PubMed ID: 28566576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics: translating functional genomics into rational therapeutics.
    Evans WE; Relling MV
    Science; 1999 Oct; 286(5439):487-91. PubMed ID: 10521338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics: past, present and future.
    Pirmohamed M
    Drug Discov Today; 2011 Oct; 16(19-20):852-61. PubMed ID: 21884816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applicability of sequence variations in genes related to drug metabolism.
    Stojiljkovic M; Patrinos GP; Pavlovic S
    Curr Drug Metab; 2011 Jun; 12(5):445-54. PubMed ID: 21453274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics: from discovery to patient care.
    Shin J; Kayser SR; Langaee TY
    Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice.
    Pilotto A; Panza F; Seripa D
    Curr Drug Metab; 2011 Sep; 12(7):621-34. PubMed ID: 21495974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs.
    Vivot A; Boutron I; Ravaud P; Porcher R
    Genet Med; 2015 Sep; 17(9):733-8. PubMed ID: 25521333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics and the future of toxicology testing.
    Agrawal YP; Rennert H
    Clin Lab Med; 2012 Sep; 32(3):509-23. PubMed ID: 22939305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics-based new therapeutic concepts.
    Roots I; Gerloff T; Meisel C; Kirchheiner J; Goldammer M; Kaiser R; Laschinski G; Brockmöller J; Cascorbi I; Kleeberg U; Hildebrandt AG
    Drug Metab Rev; 2004 Oct; 36(3-4):617-38. PubMed ID: 15554239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.